search
cancer treatment
Trends
- 1
A melanoma vaccine built on mRNA technology is in the news, with health outlets highlighting it as a promising new approach to treating the deadliest form of skin cancer. mRNA vaccines, proven at scale during the COVID-19 pandemic, are being developed to train the immune system to recognise and attack cancer cells, with several candidates now in clinical trials.
- 213-Year-Old Reported Cured of DIPG, Deadliest Childhood Brain CancerโA 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old has reportedly become the first person cured of DIPG, an incurable and almost universally fatal childhood brain cancer. News of the case, described as a world first, has spread widely online, with readers reacting to the prospect of a breakthrough against a disease that has long defied treatment and typically claims young patients' lives within months of diagnosis.
- 3CAR T cell therapy shows two years free of lupus flaresโTwo years later, CAR T cell therapy shows promise for life without lupus flares
Researchers at UMass Chan Medical School report that lupus patients treated with CAR T cell therapy have remained free of disease flares two years after receiving the one-time cell-based treatment. The therapy, originally developed for blood cancers, reprograms a patient's own immune cells, and the latest follow-up data suggest it may offer lasting remission in autoimmune disease.
- 4Researchers link cell crowding to optimal treatment timingโTreatment resistance is one of the key challenges in cancer and antibiotic therapy. Researchers led by Dr. Jona Kayser a
Researchers led by Dr. Jona Kayser at MPZPM report that physical processes in dense cell populations strongly influence the best timing of treatment cycles, with implications for both cancer therapy and antibiotics. Treatment resistance remains one of the central challenges in medicine, and the findings suggest that timing could be adjusted based on how tightly cells pack together rather than on biology alone. The work points to new ways of scheduling therapies to delay or avoid resistance.
- 5Proliferative Pause Offers Window to Prevent Brain MetastasisโผProliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that cancer cells entering a 'proliferative pause' โ a dormant, slow-dividing state โ may expose a critical window during which brain metastasis could be prevented. The finding suggests that targeting cells during this quiescent phase, before they resume growth in the brain, could open new preventive strategies against one of the deadliest consequences of cancer spread.
- 6UConn Health Launches CAR-T Cell Therapy ProgramโผUConn Health Launches Cutting-Edge CAR-T Cell Therapy Program
UConn Health has announced the launch of a new CAR-T cell therapy program, a form of immunotherapy that engineers a patient's own immune cells to fight cancer. The initiative brings an advanced, personalised cancer treatment to the Connecticut institution, expanding access for patients in the region who previously had to travel elsewhere for such therapy.
- 7Penn Medicine and IBA Launch Proton Therapy Joint VentureโผPenn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian medical technology company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will combine Penn Medicine's clinical expertise with IBA's technology to develop and expand proton therapy treatments for cancer patients.
- 8
New reporting highlights that people who survived cancer in childhood face a significantly elevated risk of serious mental health difficulties in adulthood, including depression, anxiety and other psychiatric conditions. The findings point to long-term psychological effects of early cancer diagnosis and treatment, and renew calls for survivors to receive sustained mental health monitoring and support, not just physical follow-up care, well into their adult lives.
- 9
New research suggests that analysing the biology of prostate cancer tumours can help doctors identify which patients are most likely to benefit from hormone therapy. The findings could support more personalised treatment decisions, allowing clinicians to target therapy at those most likely to respond rather than applying it universally. The report has drawn attention in medical news coverage.
- 10Building AI for Cancer Care in SomalilandโผBuilding AI for Cancer Care in SomalilandBuilding AI for Cancer Care in Somaliland
A new initiative is exploring the use of artificial intelligence to improve cancer care in Somaliland, where diagnostic infrastructure and oncology services remain limited. The effort, highlighted in professional medical circles, focuses on adapting AI tools to local healthcare needs, aiming to support earlier detection and treatment decisions in a region with few specialists. It reflects a growing interest in applying AI to low-resource health systems.
- 11Mount Sinai to test novel liquid radioembolic agent for brain tumorsโMount Sinai announces collaborative research agreement to evaluate novel liquid radioembolic agent for brain tumors
Mount Sinai has announced a collaborative research agreement to evaluate a novel liquid radioembolic agent for treating brain tumors. The therapy would deliver radiation directly to tumor tissue in liquid form, an approach being explored for cancers that are difficult to treat surgically. Details on the partner institution, trial design and timeline have not yet been released, and clinical results remain pending.